Skip to main content
Equibles
DNLI logo

DNLI · Denali Therapeutics Inc. · Webcasts, Transcripts & Audio

Track DNLI — free

Use DNLI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DNLI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.91 -0.09 (-0.45%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$3.25B
Shares
159.85M
Volume · Oct 5 1.72M Avg daily vol (3M) 1.57M

Denali Therapeutics Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Denali Therapeutics Inc. (DNLI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼31% $9.39M −$58.23M '20 Q3 20-11-05 LATEST · $3.60M −$127.55M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Denali Therapeutics Inc. (DNLI) Q2 2026 Earnings Call Transcript
Confident tone Ablea commercial launch Patient and physician engagement Transport vehicle platform
Revenue
$3.60M
Diluted EPS
$-0.68
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Denali Therapeutics Inc. (DNLI) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
Denali Therapeutics Inc. (DNLI) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2026-03-25
Denali Therapeutics Inc. (DNLI) Q4 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Denali Therapeutics Inc. (DNLI) Q3 2025 Earnings Call Transcript
Confident tone Blood-brain barrier / Transport Vehicle platform Sanfilippo enzyme replacement therapy program Alzheimer's disease programs (tau and A-beta)
Diluted EPS
$-0.74
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Denali Therapeutics Inc. (DNLI) Q3 2020 Earnings Call
Revenue
$9.39M
▼ 31% YoY
Diluted EPS
$-0.54
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–6 of 6 webcasts
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 6 filings 6 filers Visit website Investor relations